Pause of J&J vaccine will cause some cancellations
Carney and Rattay said the morning’s announcement that doses of the one-shot Johnson & Johnson will be paused nationwide after six of 6.8 million recipients developed serious blood clots could cause some delays for residents with appointments through pharmacies.
Rattay stressed that the pause was just that — a break while scientists and health regulators study the issue of blood clots — and they hope to resume giving that shot when they get the green light from the federal government.
Rattay said that state sponsored-events like the mass dosings at Dover International Speedway and other sites won’t be immediately affected for two reasons:
- The state had already shifted those events for second doses of the Pfizer or Moderna vaccines because this week’s and future shipments of the Johnson & Johnson vaccine had already been reduced substantially because up to 15 million doses had been contaminated at a Baltimore manufacturing facility.
- Demand has dipped as the state opened up registration last week to everybody 16 and older who wants one.
The governor says many people have been going to their pharmacies as appointments open up, or were already vaccinated when medical professionals, essential workers and educators were eligible.
To increase options, on Tuesday the governor also opened up vaccinations at doctor’s offices and hospital providers to anybody over 16. Previously, only those with high-risk medical conditions such as cancer or diabetes.
“I’d encourage all Delawareans to get the shot,’’ Carney said. “If you’re concerned, talk to your doctor, or members of your family and friends who have already received the vaccine. That’s how we’ll beat this virus.”